Meral Kayikcioglu/
Dec 3, 2025, 02:29
Meral Kayikcioglu: Successfully Completing FDA Inspections for Two Phase 3 Trials
Meral Kayikcioglu, Professor of Cardiology at Ege University and Director of the Lipid and Prevention Clinic, shared on LinkedIn:
“We successfully completed FDA inspections for two different Phase 3 RCTs (LIB-HoFH and HeFH)! This extremely challenging and prestigious inspection in pharmaceutical R&D processes also demonstrated our compliance with global standards.
To my knowledge, only 10 FDA inspections have been conducted in our country to date. Successfully passing one of these inspections is a source of great pride for both our team and our country. I thank all my teammates and stakeholders who contributed to this process.
We continue to work for stronger, more innovative, and more reliable science!”
Stay updated with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis